Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

Conditions:   COVID-19 Respiratory Infection;   Aspergillosis Intervention:   Drug: Posaconazole Sponsors:   Medical University of Graz;   Merck Sharp & Dohme Corp. Recruiting

Source: ClinicalTrials.gov - October 4, 2021 Category: Research Source Type: clinical trials